FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2080863619> ?p ?o ?g. }

• W2080863619 endingPage "819" @default.
• W2080863619 startingPage "813" @default.
• W2080863619 abstract "Traditional treatment of organophosphate poisoning (OP) with oximes has had limited success. Fresh frozen plasma (FFP) or albumin, acting as bioscavengers to mop up free organophosphate, has been recently proposed as a treatment modality. In this pilot open-label, three-arm, randomized controlled study exploring proof of concept, we evaluated if bioscavenger therapy had a role in OP.Sixty patients with significant poisoning presenting within 12 hours, with suppression of pseudocholinesterase activity to < 1,000 U/L, were randomized to receive FFP (8 bags, 250 mL each over 3 days), 20% human albumin (4 × 100 mL over 3 days), or saline (2,000 mL over 3 days) in addition to atropine and supportive care. Pseudocholinesterase and organophosphate levels were measured pretreatment, post-infusion (Day 2, Day 3), and predischarge and expressed as mean ± standard error. The incidence of intermediate syndrome, need for mechanical ventilation, atropine requirement, and mortality were assessed.Twenty patients received albumin and 19 patients each FFP or saline. FFP increased pseudocholinesterase levels (250 ± 44-1,241 ± 364 U/L) significantly (p = 0.007). Small, nonsignificant increases were observed with saline (160 ± 30-259 ± 78) and albumin (146 ± 18-220 ± 61). Organophosphate levels reduced in all 3 arms; no clear-cut trends were observed. We observed more cases of intermediate syndrome with FFP [10/19 (53%) vs. 5/20 (25%) vs. 5/19 (26%), FFP, albumin, and saline arms (p = 0.15)]. The interventions did not affect ventilatory requirements (14/19 vs. 15/20 vs. 14/19) or prevent delayed intubation. There were no differences in mean (±standard error) atropine requirement (in milligrams) in the first 3 days (536 ± 132 vs. 361 ± 125 vs. 789 ± 334) and duration (in days) of ventilation (10.0 ± 2.1 vs. 7.1 ± 1.5 vs. 7.5 ± 1.5) or hospital stay (12.4 ± 2.2 vs. 9.8 ± 1.4 vs. 9.8 ± 1.6). Two patients developed adverse effects with FFP. Mortality was similar (4/19 vs. 5/20 vs. 2/19, p = 0.6).Despite significant increase in pseudocholinesterase levels with FFP, this pilot study did not demonstrate favorable trends in clinical outcomes with FFP or albumin." @default.
• W2080863619 created "2016-06-24" @default.
• W2080863619 creator A5011538718 @default.
• W2080863619 creator A5014997288 @default.
• W2080863619 creator A5016126130 @default.
• W2080863619 creator A5016514548 @default.
• W2080863619 creator A5031660699 @default.
• W2080863619 creator A5040345728 @default.
• W2080863619 creator A5049721158 @default.
• W2080863619 creator A5076590893 @default.
• W2080863619 creator A5077110496 @default.
• W2080863619 creator A5079401956 @default.
• W2080863619 creator A5080988098 @default.
• W2080863619 creator A5087467382 @default.
• W2080863619 date "2010-10-01" @default.
• W2080863619 modified "2023-09-27" @default.
• W2080863619 title "Bioscavenger therapy for organophosphate poisoning – an open-labeled pilot randomized trial comparing fresh frozen plasma or albumin with saline in acute organophosphate poisoning in humans" @default.
• W2080863619 cites W1980738372 @default.
• W2080863619 cites W2003282309 @default.
• W2080863619 cites W2008507262 @default.
• W2080863619 cites W2015156720 @default.
• W2080863619 cites W2050561536 @default.
• W2080863619 cites W2060290647 @default.
• W2080863619 cites W2060588824 @default.
• W2080863619 cites W2099045381 @default.
• W2080863619 cites W2099953575 @default.
• W2080863619 cites W2102561095 @default.
• W2080863619 cites W2105336870 @default.
• W2080863619 cites W2107952228 @default.
• W2080863619 cites W2115916359 @default.
• W2080863619 cites W2118706753 @default.
• W2080863619 cites W2132223856 @default.
• W2080863619 cites W2141435131 @default.
• W2080863619 cites W2170690877 @default.
• W2080863619 cites W2337280970 @default.
• W2080863619 cites W2407471277 @default.
• W2080863619 cites W2913968977 @default.
• W2080863619 cites W4251364490 @default.
• W2080863619 doi "https://doi.org/10.3109/15563650.2010.518970" @default.
• W2080863619 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20923392" @default.
• W2080863619 hasPublicationYear "2010" @default.
• W2080863619 type Work @default.
• W2080863619 sameAs 2080863619 @default.
• W2080863619 citedByCount "26" @default.
• W2080863619 countsByYear W20808636192012 @default.
• W2080863619 countsByYear W20808636192013 @default.
• W2080863619 countsByYear W20808636192014 @default.
• W2080863619 countsByYear W20808636192015 @default.
• W2080863619 countsByYear W20808636192016 @default.
• W2080863619 countsByYear W20808636192017 @default.
• W2080863619 countsByYear W20808636192019 @default.
• W2080863619 countsByYear W20808636192020 @default.
• W2080863619 countsByYear W20808636192022 @default.
• W2080863619 countsByYear W20808636192023 @default.
• W2080863619 crossrefType "journal-article" @default.
• W2080863619 hasAuthorship W2080863619A5011538718 @default.
• W2080863619 hasAuthorship W2080863619A5014997288 @default.
• W2080863619 hasAuthorship W2080863619A5016126130 @default.
• W2080863619 hasAuthorship W2080863619A5016514548 @default.
• W2080863619 hasAuthorship W2080863619A5031660699 @default.
• W2080863619 hasAuthorship W2080863619A5040345728 @default.
• W2080863619 hasAuthorship W2080863619A5049721158 @default.
• W2080863619 hasAuthorship W2080863619A5076590893 @default.
• W2080863619 hasAuthorship W2080863619A5077110496 @default.
• W2080863619 hasAuthorship W2080863619A5079401956 @default.
• W2080863619 hasAuthorship W2080863619A5080988098 @default.
• W2080863619 hasAuthorship W2080863619A5087467382 @default.
• W2080863619 hasConcept C126322002 @default.
• W2080863619 hasConcept C141071460 @default.
• W2080863619 hasConcept C161176658 @default.
• W2080863619 hasConcept C168563851 @default.
• W2080863619 hasConcept C2775859210 @default.
• W2080863619 hasConcept C2776125364 @default.
• W2080863619 hasConcept C2776327929 @default.
• W2080863619 hasConcept C2776588719 @default.
• W2080863619 hasConcept C2777080012 @default.
• W2080863619 hasConcept C2777397205 @default.
• W2080863619 hasConcept C2778736120 @default.
• W2080863619 hasConcept C42219234 @default.
• W2080863619 hasConcept C6557445 @default.
• W2080863619 hasConcept C66112548 @default.
• W2080863619 hasConcept C71924100 @default.
• W2080863619 hasConcept C86803240 @default.
• W2080863619 hasConcept C89560881 @default.
• W2080863619 hasConceptScore W2080863619C126322002 @default.
• W2080863619 hasConceptScore W2080863619C141071460 @default.
• W2080863619 hasConceptScore W2080863619C161176658 @default.
• W2080863619 hasConceptScore W2080863619C168563851 @default.
• W2080863619 hasConceptScore W2080863619C2775859210 @default.
• W2080863619 hasConceptScore W2080863619C2776125364 @default.
• W2080863619 hasConceptScore W2080863619C2776327929 @default.
• W2080863619 hasConceptScore W2080863619C2776588719 @default.
• W2080863619 hasConceptScore W2080863619C2777080012 @default.
• W2080863619 hasConceptScore W2080863619C2777397205 @default.
• W2080863619 hasConceptScore W2080863619C2778736120 @default.
• W2080863619 hasConceptScore W2080863619C42219234 @default.
• W2080863619 hasConceptScore W2080863619C6557445 @default.
• W2080863619 hasConceptScore W2080863619C66112548 @default.

• next